• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Carbohydrates - Guidelines on Parenteral Nutrition, Chapter 5.碳水化合物——肠外营养指南,第5章。
Ger Med Sci. 2009 Nov 18;7:Doc23. doi: 10.3205/000082.
2
Lipid emulsions - Guidelines on Parenteral Nutrition, Chapter 6.脂质乳剂——肠外营养指南,第6章。
Ger Med Sci. 2009 Nov 18;7:Doc22. doi: 10.3205/000081.
3
Water, electrolytes, vitamins and trace elements - Guidelines on Parenteral Nutrition, Chapter 7.水、电解质、维生素和微量元素——肠外营养指南,第7章。
Ger Med Sci. 2009 Nov 18;7:Doc21. doi: 10.3205/000080.
4
Intensive medicine - Guidelines on Parenteral Nutrition, Chapter 14.重症医学——肠外营养指南,第14章。
Ger Med Sci. 2009 Nov 18;7:Doc14. doi: 10.3205/000073.
5
Amino acids - Guidelines on Parenteral Nutrition, Chapter 4.氨基酸 - 肠外营养指南,第4章。
Ger Med Sci. 2009 Nov 18;7:Doc24. doi: 10.3205/000083.
6
Gastroenterology - Guidelines on Parenteral Nutrition, Chapter 15.胃肠病学 - 肠外营养指南,第15章。
Ger Med Sci. 2009 Nov 18;7:Doc13. doi: 10.3205/000072.
7
Practical handling of AIO admixtures - Guidelines on Parenteral Nutrition, Chapter 10.全合一肠外营养液的实际操作——《肠外营养指南》第10章
Ger Med Sci. 2009 Nov 18;7:Doc18. doi: 10.3205/000077.
8
Complications and monitoring - Guidelines on Parenteral Nutrition, Chapter 11.并发症与监测——肠外营养指南,第11章
Ger Med Sci. 2009 Nov 18;7:Doc17. doi: 10.3205/000076.
9
Surgery and transplantation - Guidelines on Parenteral Nutrition, Chapter 18.外科手术与移植——肠外营养指南,第18章。
Ger Med Sci. 2009 Nov 18;7:Doc10. doi: 10.3205/000069.
10
Introduction and methodology - Guidelines on Parenteral Nutrition, Chapter 1.引言与方法——肠外营养指南,第1章
Ger Med Sci. 2009 Nov 18;7:Doc26. doi: 10.3205/000085.

引用本文的文献

1
Nutritional Optimization of the Surgical Patient: A Narrative Review.手术患者的营养优化:一篇叙述性综述。
Adv Nutr. 2025 Jan;16(1):100351. doi: 10.1016/j.advnut.2024.100351. Epub 2024 Nov 29.
2
Peroxisome-Deficiency and HIF-2α Signaling Are Negative Regulators of Ketohexokinase Expression.过氧化物酶体缺乏与低氧诱导因子-2α信号传导是己酮糖激酶表达的负调节因子。
Front Cell Dev Biol. 2020 Jul 8;8:566. doi: 10.3389/fcell.2020.00566. eCollection 2020.
3
Disparate Candida albicans Biofilm Formation in Clinical Lipid Emulsions Due to Capric Acid-Mediated Inhibition.由于癸酸介导的抑制作用,临床脂肪乳剂中白色念珠菌生物膜形成的差异。
Antimicrob Agents Chemother. 2019 Oct 22;63(11). doi: 10.1128/AAC.01394-19. Print 2019 Nov.
4
Energy, Protein, Carbohydrate, and Lipid Intakes and Their Effects on Morbidity and Mortality in Critically Ill Adult Patients: A Systematic Review.危重症成年患者的能量、蛋白质、碳水化合物和脂质摄入量及其对发病率和死亡率的影响:一项系统评价
Adv Nutr. 2017 Jul 14;8(4):624-634. doi: 10.3945/an.117.015172. Print 2017 Jul.
5
Incidence of nutritional support complications in patient hospitalized in wards. multicentric study.病房住院患者营养支持并发症的发生率。多中心研究。
Colomb Med (Cali). 2012 Jun 30;43(2):147-53. eCollection 2012 Apr.
6
[Nutritional management of severely injured patients : Treatment between guidelines and reality].[严重创伤患者的营养管理:指南与现实之间的治疗]
Unfallchirurg. 2011 Nov;114(11):973-80. doi: 10.1007/s00113-011-2032-8.

本文引用的文献

1
Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus.入院血糖水平作为伴或不伴糖尿病的心肌梗死患者死亡风险指标。
Arch Intern Med. 2004 May 10;164(9):982-8. doi: 10.1001/archinte.164.9.982.
2
Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients.重症患者异质性群体中高血糖与医院死亡率增加之间的关联。
Mayo Clin Proc. 2003 Dec;78(12):1471-8. doi: 10.4065/78.12.1471.
3
Glucose control and mortality in critically ill patients.危重症患者的血糖控制与死亡率
JAMA. 2003 Oct 15;290(15):2041-7. doi: 10.1001/jama.290.15.2041.
4
Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome.持续性卒中后高血糖与梗死灶扩大及更差的临床预后独立相关。
Stroke. 2003 Sep;34(9):2208-14. doi: 10.1161/01.STR.0000085087.41330.FF. Epub 2003 Jul 31.
5
Blood glucose management during critical illness.危重症期间的血糖管理
Rev Endocr Metab Disord. 2003 May;4(2):187-94. doi: 10.1023/a:1022998204978.
6
Clinical potential of insulin therapy in critically ill patients.胰岛素治疗在危重症患者中的临床潜力。
Drugs. 2003;63(7):625-36. doi: 10.2165/00003495-200363070-00001.
7
Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control.重症患者强化胰岛素治疗的预后益处:胰岛素剂量与血糖控制
Crit Care Med. 2003 Feb;31(2):359-66. doi: 10.1097/01.CCM.0000045568.12881.10.
8
Effect of salt and water balance on recovery of gastrointestinal function after elective colonic resection: a randomised controlled trial.盐和水平衡对择期结肠切除术后胃肠功能恢复的影响:一项随机对照试验
Lancet. 2002 May 25;359(9320):1812-8. doi: 10.1016/S0140-6736(02)08711-1.
9
Effect of age on substrate oxidation during total parenteral nutrition.年龄对全胃肠外营养期间底物氧化的影响。
Nutrition. 2002 Jan;18(1):20-5. doi: 10.1016/s0899-9007(01)00697-9.
10
Intensive insulin therapy in critically ill patients.危重症患者的强化胰岛素治疗
N Engl J Med. 2001 Nov 8;345(19):1359-67. doi: 10.1056/NEJMoa011300.

碳水化合物——肠外营养指南,第5章。

Carbohydrates - Guidelines on Parenteral Nutrition, Chapter 5.

作者信息

Bolder U, Ebener C, Hauner H, Jauch K W, Kreymann G, Ockenga J, Traeger K

机构信息

Dept. of Surgery, University of Regensburg, Germany.

出版信息

Ger Med Sci. 2009 Nov 18;7:Doc23. doi: 10.3205/000082.

DOI:10.3205/000082
PMID:20049080
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2795380/
Abstract

The main role of carbohydrates in the human body is to provide energy. Carbohydrates should always be infused with PN (parenteral nutrition) in combination with amino acids and lipid emulsions to improve nitrogen balance. Glucose should be provided as a standard carbohydrate for PN, whereas the use of xylite is not generally recommended. Fructose solutions should not be used for PN. Approximately 60% of non-protein energy should be supplied as glucose with an intake of 3.0-3.5 g/kg body weight/day (2.1-2.4 mg/kg body weight/min). In patients with a high risk of hyperglycaemia (critically ill, diabetes, sepsis, or steroid therapy) an lower initial carbohydrate infusion rate of 1-2 g/kg body weight/day is recommended to achieve normoglycaemia. One should aim at reaching a blood glucose level of 80-110 mg/dL, and at least a glucose level <145 mg/dL should be achieved to reduce morbidity and mortality. Hyperglycaemia may require addition of an insulin infusion or a reduction (2.0-3.0 g/kg body weight/day) or even a temporary interruption of glucose infusion. Close monitoring of blood glucose levels is highly important.

摘要

碳水化合物在人体中的主要作用是提供能量。碳水化合物应始终与氨基酸和脂肪乳剂联合用于肠外营养(PN),以改善氮平衡。葡萄糖应作为PN的标准碳水化合物提供,而一般不推荐使用木糖醇。果糖溶液不应用于PN。约60%的非蛋白质能量应以葡萄糖形式提供,摄入量为3.0 - 3.5克/千克体重/天(2.1 - 2.4毫克/千克体重/分钟)。对于有高血糖风险的患者(重症患者、糖尿病患者、脓毒症患者或接受类固醇治疗的患者),建议初始碳水化合物输注速率较低,为1 - 2克/千克体重/天,以实现血糖正常。目标应是使血糖水平达到80 - 110毫克/分升,并且至少应达到血糖水平<145毫克/分升,以降低发病率和死亡率。高血糖可能需要添加胰岛素输注或减少(2.0 - 3.0克/千克体重/天)甚至暂时中断葡萄糖输注。密切监测血糖水平非常重要。